 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.
SUMMARIES FOR PATIENTS
Predicting Recovery of Heart Muscle Strength after a Heart Attack
20 March 2001 | Volume 134 Issue 6 | Page S90
Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians-American Society of Internal Medicine.
The summary below is from the full report titled "Recovery of Ventricular Function after Myocardial Infarction in the Reperfusion Era: The Healing and Early Afterload Reducing Therapy Study." It is in the 20 March 2001 issue of Annals of Internal Medicine (volume 134, pages 451-458). The authors are SD Solomon, RJ Glynn, S Greaves, U Ajani, J-L Rouleau, F Menapace, JMO Arnold, C Hennekens, and MA Pfeffer.
What is the problem and what is known about it so far?
Severe blockage of the arteries that supply blood to heart muscle is known as a heart attack (the medical term is "myocardial infarction"). Heart muscle is weakened immediately after a heart attack but gradually regains its strength. Occasionally, the heart muscle progressively weakens, leading to chronic failure of the heart to work as an efficient pump. Although several techniques and drugs are used to improve blood flow to heart muscle rapidly after a heart attack (known as reperfusion therapy), the factors that influence development or improvement of heart muscle weakness are not known.
Why did the researchers do this particular study?
To see whether clinical or laboratory test characteristics can predict recovery of heart muscle strength after a heart attack.
Who was studied?
249 patients with heart attacks who had undergone reperfusion therapy. These patients had taken part in a separate study of treatment with several different doses of a drug that reduces the workload on the heart (the Healing and Early Afterload Reduction Therapy [HEART] study).
How was the study done?
The researchers reanalyzed data from the HEART study, including clinical characteristics; blood tests for creatine kinase (CK); and the results of echocardiography done 1, 14, and 90 days after patients' heart attacks. Creatine kinase is a chemical that spills into the bloodstream when heart muscle cells are damaged. Echocardiography uses sound waves to analyze heart size and muscle function.
What did the researchers find?
Patients with the highest levels of CK in their blood were least likely to have complete recovery of heart muscle strength. In addition, patients with enlargement of the left ventricle (the main pumping chamber of the heart) during the 90-day observation period were less likely to show improvement in overall pumping ability, although a few patients with such enlargement did have improvement. Only 26% of patients with any degree of left ventricular enlargement recovered complete strength of the heart muscle.
What were the limitations of the study?
The groups that received different doses of the drug that reduces workload of the heart all recovered heart muscle function about equally. The study therefore does not tell us whether drugs of this kind can improve recovery of heart muscle function. Moreover, the researchers could not tell which patients actually achieved reperfusion and which did not. Thus, they could not tell whether successful reperfusion improved recovery of heart muscle strength. Finally, only one type of heart attack was studied; the results of this study may not apply to other types.
What are the implications of the study?
Measuring CK levels in the blood and testing for enlargement of the heart by using echocardiography can help predict which patients will recover heart muscle strength after a heart attack.
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  K. D. Sjauw, M. Remmelink, J. Baan Jr, K. Lam, A. E. Engstrom, R. J. van der Schaaf, M. M. Vis, K. T. Koch, J. P. van Straalen, J. G.P. Tijssen, et al. Left ventricular unloading in acute ST-segment elevation myocardial infarction patients is safe and feasible and provides acute and sustained left ventricular recovery. J. Am. Coll. Cardiol., March 11, 2008; 51(10): 1044 - 1046. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Menasche, O. Alfieri, S. Janssens, W. McKenna, H. Reichenspurner, L. Trinquart, J.-T. Vilquin, J.-P. Marolleau, B. Seymour, J. Larghero, et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) Trial: First Randomized Placebo-Controlled Study of Myoblast Transplantation Circulation, March 4, 2008; 117(9): 1189 - 1200. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Guazzi, R. Arena, and M. D. Guazzi Evolving changes in lung interstitial fluid content after acute myocardial infarction: mechanisms and pathophysiological correlates Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1357 - H1364. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. V. Exner, K. M. Kavanagh, M. P. Slawnych, L. B. Mitchell, D. Ramadan, S. G. Aggarwal, C. Noullett, A. Van Schaik, R. T. Mitchell, M. A. Shibata, et al. Noninvasive Risk Assessment Early After a Myocardial Infarction: The REFINE Study J. Am. Coll. Cardiol., December 11, 2007; 50(24): 2275 - 2284. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Verma, N. S. Anavekar, A. Meris, J. J. Thune, J. M. O. Arnold, J. K. Ghali, E. J. Velazquez, J. J.V. McMurray, M. A. Pfeffer, and S. D. Solomon The Relationship Between Renal Function and Cardiac Structure, Function, and Prognosis After Myocardial Infarction: The VALIANT Echo Study J. Am. Coll. Cardiol., September 25, 2007; 50(13): 1238 - 1245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Nakashima, T. Katayama, C. Takagi, K. Amenomori, M. Ishizaki, Y. Honda, and S. Suzuki Obstructive sleep apnoea inhibits the recovery of left ventricular function in patients with acute myocardial infarction Eur. Heart J., October 1, 2006; 27(19): 2317 - 2322. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Banz, O. M. Hess, S. C. Robson, D. Mettler, P. Meier, A. Haeberli, E. Csizmadia, E. Y. Korchagina, N. V. Bovin, and R. Rieben Locally targeted cytoprotection with dextran sulfate attenuates experimental porcine myocardial ischaemia/reperfusion injury Eur. Heart J., November 1, 2005; 26(21): 2334 - 2343. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. F. Hernandez, E. J. Velazquez, S. D. Solomon, R. Kilaru, R. Diaz, C. M. O'Connor, G. Ertl, A. P. Maggioni, J.-L. Rouleau, W. van Gilst, et al. Left Ventricular Assessment in Myocardial Infarction: The VALIANT Registry Arch Intern Med, October 10, 2005; 165(18): 2162 - 2169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Solomon, H. Skali, N. S. Anavekar, M. Bourgoun, S. Barvik, J. K. Ghali, J. W. Warnica, M. Khrakovskaya, J. M. O. Arnold, Y. Schwartz, et al. Changes in Ventricular Size and Function in Patients Treated With Valsartan, Captopril, or Both After Myocardial Infarction Circulation, June 28, 2005; 111(25): 3411 - 3419. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J G F Cleland, A Torabi, and N K Khan Epidemiology and management of heart failure and left ventricular systolic dysfunction in the aftermath of a myocardial infarction Heart, May 1, 2005; 91(suppl_2): ii7 - ii13. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Velazquez and M. A. Pfeffer Acute Heart Failure Complicating Acute Coronary Syndromes: A Deadly Intersection Circulation, February 3, 2004; 109(4): 440 - 442. [Full Text] [PDF]
|
|
|
|
|
|
B. Scheller, B. Hennen, B. Hammer, J. Walle, C. Hofer, V. Hilpert, H. Winter, G. Nickenig, M. Bohm, and SIAM III Study Group Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction J. Am. Coll. Cardiol., August 20, 2003; 42(4): 634 - 641. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Hohnloser and B. J. Gersh Changing Late Prognosis of Acute Myocardial Infarction: Impact on Management of Ventricular Arrhythmias in the Era of Reperfusion and the Implantable Cardioverter-Defibrillator Circulation, February 25, 2003; 107(7): 941 - 946. [Full Text] [PDF]
|
|
|
|
|
|
E. O. Weinberg, M. Shimpo, G. W. De Keulenaer, C. MacGillivray, S.-i. Tominaga, S. D. Solomon, J.-L. Rouleau, and R. T. Lee Expression and Regulation of ST2, an Interleukin-1 Receptor Family Member, in Cardiomyocytes and Myocardial Infarction Circulation, December 3, 2002; 106(23): 2961 - 2966. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Solomon, M. S. J. Sutton, G. A. Lamas, T. Plappert, J. L. Rouleau, H. Skali, L. Moye, E. Braunwald, M. A. Pfeffer, and for the Survival And Ventricular Enlargement (SAVE Ventricular Remodeling Does Not Accompany the Development of Heart Failure in Diabetic Patients After Myocardial Infarction Circulation, September 3, 2002; 106(10): 1251 - 1255. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Post-MI Recovery of Ventricular Function Journal Watch Cardiology, June 1, 2001; 2001(601): 12 - 12. [Full Text]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article
